Free Trial

Benchmark's Rating of CapsoVision on 7/28/2025

On July 28, 2025, Benchmark updated its outlook on CapsoVision (NASDAQ:CV) with the action "Initiated Coverage", setting a "Speculative Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Benchmark Co.

DateCompanyAction
9/10/2025
Aeluma, Inc. stock logo
ALMU
Aeluma
Reiterated Rating
9/10/2025
Porch Group, Inc. stock logo
PRCH
Porch Group
Boost Price Target
9/10/2025
Genius Sports Limited stock logo
GENI
Genius Sports
Boost Price Target
9/10/2025
Clene Inc. stock logo
CLNN
Clene
Lower Price Target
9/10/2025
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
Lower Price Target
9/9/2025
Semtech Corporation stock logo
SMTC
Semtech
Boost Price Target
More Ratings From Benchmark Co.